Total Funding
65
35
Total FundingSeries D raised
Growth Score 65 in past quarter
-2 pts
Heat Score 35 in past quarter
-2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
40552
Worg Pharmaceuticals is a clinical stage biopharmaceutical company developing new treatments for allergies and other diseases.
- Andrew Xu: Chairman & CEO
- Rainer Henning: Chief Scientific Officer and Head of European Operations
About the Company
Worg Pharmaceuticals is a clinical-stage biopharmaceutical company developing new treatments for allergies and other diseases. The company is building a pipeline for allergy and autoimmune diseases based on two technology platforms, PCFiT and Apitope, through internal development and external collaboration with flexible business models. Worg is
also developing a platform for molecular allergy diagnosis.